Intensified Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Anus—A Population-Based Experience from the Danish Anal Cancer Group
Open Access
- 28 June 2021
- Vol. 13 (13), 3226
- https://doi.org/10.3390/cancers13133226
Abstract
Locally advanced squamous cell carcinoma of the anus (LASCCA) has a poor prognosis with a high risk of treatment failure calling for intensified therapy. We present the long-term follow-up of a nationwide cohort of LASCCA treated with intensified induction chemotherapy (ICT). The study included patients with LASCCA (T3-4N0 or T1-4N+) treated with at least one cycle of ICT (cisplatin, ifosfamide, leucoverin, and 5-flourouracil) between 1998–2018. Data were retrospectively collected from medical records, and statistics were performed in STATA 16.1. In total, 166 patients with LASCCA were identified. Following ICT, 157 patients (95%) received primary curative treatment with either radiotherapy (70%), chemoradiotherapy (27%), or abdominal perineal resection (3%). The overall local tumor response rate after ICT was 76% with 20 (13%) achieving complete local tumor response. After the primary treatment, 123 patients (79%) obtained complete response, and 27 underwent salvage surgery due to persistent disease. The median follow-up time was 6 years, local and distant failure rates 22% and 13%, respectively. The 3- and 5-year disease-free survival rates were 70% and 67%, and the 3- and 5-year overall survival rates were 76% and 70%, respectively. Intensified ICT regimen could be a supplementary treatment option in the most advanced cases of LASCCA. Prospective randomized trials are needed to investigate this approach further.Funding Information
- Kræftens Bekæmpelse (.)
- Aarhus Universitet (.)
- Danish Comprehensive Cancer Center – Radiotherapy (.)
This publication has 30 references indexed in Scilit:
- Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 TrialJournal of Clinical Oncology, 2012
- Twenty-Five-Year Experience With Radical Chemoradiation for Anal CancerInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Relationship Between Radiation Treatment Time and Overall Survival After Induction Chemotherapy for Locally Advanced Head-and-Neck Carcinoma: A Subset Analysis of TAX 324International Journal of Radiation Oncology*Biology*Physics, 2011
- “Mind the Gap”—The Impact of Variations in the Duration of the Treatment Gap and Overall Treatment Time in the First UK Anal Cancer Trial (ACT I)International Journal of Radiation Oncology*Biology*Physics, 2011
- Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87-04 and 98-11Journal of Clinical Oncology, 2010
- Prognostic factors derived from a prospective database dictate clinical biology of anal cancerCancer, 2010
- Induction Therapy for Poor-Prognosis Anal Canal Carcinoma: A Phase II Study of the Cancer and Leukemia Group B (CALGB 9281)Journal of Clinical Oncology, 2008
- Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal CancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Cisplatin, 5-Fluorouracil, and Ifosfamide in the Treatment of Recurrent or Advanced Cervical CancerGynecologic Oncology, 1995
- A Phase II Trial of Ifosfamide, 5-Fluorouracil, and Leucovorin in Recurrent Uterine Cervical CancerGynecologic Oncology, 1994